Preparation, Characterization and Evaluation of Quetiapine Fumarate Solid Lipid Nanoparticles to Improve the Oral Bioavailability

Figure 4

Serum concentration versus time profile of quetiapine fumarate upon oral administration of SLN preparation (F3) and suspension (F7) in rats.